Citius Pharmaceuticals
CTXR
11 hedge funds and large institutions have $3.58M invested in Citius Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.
485% more capital invested
Capital invested by funds: $613K → $3.58M (+$2.97M)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
10% more funds holding
Funds holding: 10 → 11 (+1)
0.38% more ownership
Funds ownership: 0.11% → 0.49% (+0.38%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$2.32M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$892K |
| 3 |
MIM
Miller Investment Management
West Conshohocken,
Pennsylvania
|
+$21.1K |
| 4 |
VF
Virtu Financial
New York
|
+$17.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$50K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$14K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $2.47M | +$2.32M | +87,895 | New |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $640K | +$892K | +33,817 | New |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $360K | +$14.8K | +563 | +3% |
|
|
BAAM
4
Baker Avenue Asset Management
San Francisco,
California
| $70K | +$8.44K | +320 | +9% |
|
|
MIM
5
Miller Investment Management
West Conshohocken,
Pennsylvania
| $15K | +$21.1K | +800 | New |
|
|
VF
6
Virtu Financial
New York
| $13K | +$17.4K | +661 | New |
|
|
RJA
7
Raymond James & Associates
St Petersburg,
Florida
| $9K | – | – | – |
|
8
Bank of America
Charlotte,
North Carolina
| $5K | +$3.37K | +128 | +135% |
|
9
Wells Fargo
San Francisco,
California
| $2K | – | – | – |
|
|
HCM
10
Hilton Capital Management
Garden City,
New York
| $1K | – | – | – |
|
|
LTFS
11
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
12
Renaissance Technologies
New York
| – | -$50K | -2,053 | Closed |
|
|
13
Dimensional Fund Advisors
Austin,
Texas
| – | -$14K | -558 | Closed |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$4K | -146 | Closed |
|
CTXR Hedge Fund Activity: Q3 2019 in Review
11 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Citius Pharmaceuticals (CTXR) for Q3 2019, worth a combined $3.58M — up 485% from $613K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CTXR positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $2.32M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $50K sold.
- 11 institutional investors held Citius Pharmaceuticals (CTXR) as of Q3 2019, up from 10 in Q2 2019.
- Funds reported $3.58M of Citius Pharmaceuticals stock for Q3 2019, up 485% quarter-over-quarter.
- 4 funds opened new Citius Pharmaceuticals positions in Q3 2019 and 3 closed out, a net change of +1 holder.
- The largest Citius Pharmaceuticals buyer in Q3 2019 was Armistice Capital, an estimated $2.32M added.
- The largest Citius Pharmaceuticals seller in Q3 2019 was Renaissance Technologies, an estimated $50K sold.
Based on aggregated 13F filings for Q3 2019.